Article info

Download PDFPDF

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

Authors

  1. a michael.fehlings{at}immunoscape.com
  2. b jhunjhunwala.suchit{at}gene.com
  3. c marcinkowanetz{at}gmail.com
  4. d ogormanw{at}gene.com
  5. e hegde.priti{at}gene.com
  6. f hermi.sumatoh{at}immunoscape.com
  7. g boonheng.lee{at}immunoscape.com
  8. h alessandra.nardin{at}lmmunoscape.com
  9. i ebecht{at}fredhutch.org
  10. j flynn.susan{at}gene.com
  11. k ballinger.marcus{at}gene.com
  12. l enewell{at}fredhutch.org
  13. m yadav.mahesh{at}gene.com
View Full Text

Citation

Fehlings M, Jhunjhunwala S, Kowanetz M, et al
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

Publication history

  • Received April 23, 2019
  • Accepted July 25, 2019
  • First published September 12, 2019.
Online issue publication 
September 12, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.